loading

Press Releases

 

INVITRO INTERNATIONAL’S Y2K RESULTS

January, 2001 — Feature added global government support

INVITRO INTERNATIONAL REPORTS 1ST HALF 2000 OPERATING INCOME ON INCREASED SALES

May, 2000 — U.S. Government Agency Approvals expected to brighten future

INVITRO INTERNATIONAL POSTS 4TH CONSECUTIVE PROFITABLE QUARTER

Jan, 2000 — Full year ’99 sales up 16%, net profit at 9.4%

INVITRO INTERNATIONAL POSTS 3RD CONSECUTIVE PROFITABLE QUARTER

Aug, 1999 — Company also receives Corrositex endorsement from government sponsored science panel

INVITRO INTERNATIONAL REPORTS SECOND QUARTER PROFITS

May, 1999 — Sales & Cash Increase 6th Consecutive Quarter

INVITRO INTERNATIONAL REPORTS FIRST QUARTER PROFITABLE

February, 1999 — Sales & Cash Increase 5th Consecutive Quarter

INVITRO INTERNATIONAL REPORTS FOURTH QUARTER PROFITABLE, BEFORE INVENTORY WRITE OFF

January, 1999 — Sales & Cash Increase 4th Consecutive Quarter

INVITRO SALES, CASH INCREASE AGAIN; MERGER PLANS UPDATE

July, 1998 — Revenues and cash increase third consecutive quarter

INVESTOR RELATIONS FIRM SIGNED

June, 1998 — Makenna Delaney & Sullivan, Inc. to assist the firm

FINANCIAL HIGHLIGHTS

May, 1998 — Revenue Increases 2% Over Previous Quarter

PRESIDENT’S LETTER

January, 1998 — Lowest Quarterly Loss Since Becoming A Public Company

FINANCIAL HIGHLIGHTS

January, 1998 — First Quarter ended December 31, 1997

FINANCIAL HIGHLIGHTS

November, 1997 — Fiscal Year Ended September 30, 1997

INVITRO INTERNATIONAL REPORTS THIRD QUARTER RESULTS

August 15, 1997 — Company Announces Lowest Quarterly Loss and Expands Merger Options

INVITRO INTERNATIONAL REPORTS SECOND QUARTER RESULTS

May 15, 1997 — Company Signs Merger Letter Of Intent With Miragen

INVITRO INTERNATIONAL SIGNS MERGER LETTER OF INTENT

March 3, 1997 — IVI announces it has signed a letter of intent to merge with Shenyang International Inc.

INVITRO INTERNATIONAL REPORTS FIRST QUARTER RESULTS

February 4, 1997 — Board Of Directors Defer Decision To Implement 1-For-10 Reverse Stock Split Recently Approved By Shareholders

INVITRO INTERNATIONAL REPORTS YEAR-END RESULTS

December 18, 1996 — Net Annual Loss Lowest In Company’s Public History

InVitro International
330 E. Orangethorpe Ave., Suite D
Placentia, CA 92870

800-2-INVITRO (800-246-8487)
949-851-8356 (International callers)
949- 851-4985 Fax

invitro@invitrointl.com